Ads
related to: therapeutic procedures for influenza virus- Wipe Products
Wipes For Any Mess​
Eliminate Unwanted Germs​
- Clorox® Wipes
Kills 99.9% Of Virus & Bacteria​
Beat Cold & Flu W/ Clorox® Wipes
- Spray Products
Great For Everyday Messes
Bleach-Free & Bleach Sprays
- Surprising Uses
Learn About All The Places Clorox®
Can Be Used In Your Home!
- Bleach Products
Clean, Whiten, And Sanitize
Keep Your Home Clean
- Clorox® Spray
Kills 99.9% Of Bacteria & Viruses
Flu? Clorox® Spray Got You
- Wipe Products
Search results
Results From The WOW.Com Content Network
Treatments for influenza include a range of medications and therapies that are used in response to disease influenza. Treatments may either directly target the influenza virus itself; or instead they may just offer relief to symptoms of the disease, while the body's own immune system works to recover from infection.
A therapeutic interfering particle is an antiviral preparation that reduces the replication rate and pathogenesis of a particular viral infectious disease. A therapeutic interfering particle is typically a biological agent (i.e., nucleic acid) engineered from portions of the viral genome being targeted.
Rimantadine inhibits influenza activity by binding to amino acids in the M2 transmembrane channel and blocking proton transport across the M2 channel. [7] Rimantadine is believed to inhibit influenza's viral replication, possibly by preventing the uncoating of the virus's protective shells, which are the envelope and capsid.
Influvac and its quadrivalent formulation are surface antigen subunit vaccines marketed by Mylan.. Influvac; Influvac Tetra [8]; They contain inactivated purified surface fragments (subunits) from the three different strains of the influenza virus (A/H1N1, A/H3N2, and Influenza B virus) that are selected and distributed by the World Health Organization, on the basis of their latest ...
[citation needed] In September 2009, a live attenuated influenza vaccine for the novel H1N1 influenza virus was approved [28] and the seasonal intranasal vaccine was approved by the European Medicines Agency (EMA) for use in the European Union in 2011. [5] The quadrivalent version was approved for use in the European Union in 2013. [6]
Most of the antiviral drugs now available are designed to help deal with HIV, herpes viruses, the hepatitis B and C viruses, and influenza A and B viruses. [6] Viruses use the host's cells to replicate and this makes it difficult to find targets for the drug that would interfere with the virus without also harming the host organism's cells.
Ad
related to: therapeutic procedures for influenza virus